Related Experiment Video
Updated: Jun 9, 2026
A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster
Published on: September 11, 2013
A drosophila model for EGFR-Ras and PI3K-dependent human glioma
Renee D Read1, Webster K Cavenee, Frank B Furnari
1Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, California, United States of America. rread@salk.edu
Abstract:
Gliomas, the most common malignant tumors of the nervous system, frequently harbor mutations that activate the epidermal growth factor receptor (EGFR) and phosphatidylinositol-3 kinase (PI3K) signaling pathways. To investigate the genetic basis of this disease, we developed a glioma model in Drosophila. We found that constitutive coactivation of EGFR-Ras and PI3K pathways in Drosophila glia and glial precursors gives rise to neoplastic, invasive glial cells that create transplantable tumor-like growths, mimicking human glioma. Our model represents a robust organotypic and cell-type-specific Drosophila cancer model in which malignant cells are created by mutations in signature genes and pathways thought to be driving forces in a homologous human cancer. Genetic analyses demonstrated that EGFR and PI3K initiate malignant neoplastic transformation via a combinatorial genetic network composed primarily of other pathways commonly mutated or activated in human glioma, including the Tor, Myc, G1 Cyclins-Cdks, and Rb-E2F pathways. This network acts synergistically to coordinately stimulate cell cycle entry and progression, protein translation, and inappropriate cellular growth and migration. In particular, we found that the fly orthologs of CyclinE, Cdc25, and Myc are key rate-limiting genes required for glial neoplasia. Moreover, orthologs of Sin1, Rictor, and Cdk4 are genes required only for abnormal neoplastic glial proliferation but not for glial development. These and other genes within this network may represent important therapeutic targets in human glioma.
Insights
Researchers created a Drosophila glioma model by activating key signaling pathways. This model revealed a genetic network driving tumor growth, highlighting potential therapeutic targets for human glioma.
Area of Science:
- Cancer Biology
- Genetics
- Neuro-oncology
Background:
- Gliomas are common nervous system tumors often driven by mutations in epidermal growth factor receptor (EGFR) and phosphatidylinositol-3 kinase (PI3K) pathways.
- Understanding the genetic underpinnings of glioma is crucial for developing effective treatments.
Purpose of the Study:
- To develop a Drosophila model for studying glioma genetics.
- To identify the genetic network involved in glioma development and progression.
Main Methods:
- Created a Drosophila glioma model by coactivating EGFR-Ras and PI3K pathways in glial cells.
- Utilized genetic analyses to investigate the molecular pathways involved in neoplastic transformation.
Main Results:
- The Drosophila model successfully mimicked human glioma, producing neoplastic, invasive glial cells and transplantable tumor-like growths.
- EGFR and PI3K initiate transformation through a combinatorial genetic network involving Tor, Myc, G1 Cyclins-Cdks, and Rb-E2F pathways.
- Key rate-limiting genes for glial neoplasia include fly orthologs of CyclinE, Cdc25, and Myc. Genes like Sin1, Rictor, and Cdk4 are specifically required for neoplastic proliferation.
Conclusions:
- The Drosophila glioma model provides a robust platform for studying cancer genetics.
- The identified genetic network offers insights into glioma pathogenesis and suggests potential therapeutic targets for human glioma.
